Avelo mission is to save lives by bringing fast and actionable infectious disease diagnoses to primary care.
Avelo's investors include Zürcher Kantonal Bank, Venture Kick, Privilège Ventures, Arve Capital, OCCIDENT.
Avelo is headquartered in Schlieren, Switzerland.
Avelo mission is to save lives by bringing fast and actionable infectious disease diagnoses to primary care.
Avelo is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Avelo — Funding & Investors." VCBacked, December 12, 2022, https://www.vcbacked.co/company/avelo. Accessed September 29, 2026.
VCBacked. (2022). Avelo — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/avelo
{{cite web |title=Avelo — Funding & Investors |url=https://www.vcbacked.co/company/avelo |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated